ADVERTISEMENT
Clinical Trial Update
LINC Interview: The Latest on the REALITY Study
04/26/2021
The REALITY (DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions) trial evaluated the safety and effectiveness of directional atherectomy (DA) devices (HawkOne and TurboHawk; Medtronic) in combination with the IN.PACT Admiral drug-coated balloon (DCB; Medtronic) in severely calcified femoropopliteal artery atherosclerotic lesions. Listen as Ravish Sachar, MD, FACC, discusses the REALITY trial in this 3-minute video.
